Author

Catherine McNamara

Catherine McNamara, PharmD, BCPS, is a clinical pharmacogenomics specialist at an academic medical center in Boulder, Colorado. She directs a clinical testing service focused on gene-based dosing and investigates how variations in CYP enzymes affect drug response and patient toxicity. McNamara received her PhD in pharmaceutical sciences from the University of California, San Francisco, and she contributes to Biology Insights on medication science.

MRA Medication: How It Works, Uses, Types & Side Effects
Fazirsiran: A Treatment for Alpha-1 Liver Disease
What Is an Orexin Receptor Antagonist?
What Is PK/PD Modeling and Why Does It Matter?
How to Calculate AUC in Pharmacokinetics
How Is Aspirin Metabolized by the Body?
What Are CYP3A4 Drugs? Inhibitors, Inducers & Substrates
How Ibuprofen Metabolism Works in the Body
How Is Adderall Metabolized: Liver, Genes and pH
How Is Vyvanse Metabolized: Prodrug to Dextroamphetamine
Acetaminophen Metabolism: Key Pathways and Factors
CYP450 Inhibitors and Medication Interactions
What Is AUC in Pharmacokinetics and Why Does It Matter?
What Is Area Under the Curve (AUC) in Pharmacokinetics?
What Is a Serotonin Modulator and How Does It Work?
What Does Intermediate Metabolizer Mean?
What Drugs Are Metabolized by CYP2D6?
How Are NSAIDs Metabolized in the Body?
What Is Cmax in Pharmacokinetics and Why Does It Matter?
Belsomra’s Mechanism of Action: How It Works
Cytochrome P450 Enzymes: Function, Drug Impact, and Safety
What Is the Ketamine Receptor & How Does It Work?
Janssen’s Milvexian: The New Factor XIa Inhibitor
What Is Tissue Plasminogen? Function, Uses, and Risks
What Is Drug Clearance and How Does It Work?
What Is a DPP1 Inhibitor and How Does It Work?
What Is an SCD1 Inhibitor and How Does It Work?
Vesigen Therapeutics: A New Frontier in Drug Delivery
What is Ibudilast and How Does It Work?
Patisiran FDA Approval for hATTR Amyloidosis Explained